Answers are grounded in this paper and cite their sources.
Reveals autoantibody and T-cell receptor cross-reactivity with myelin basic protein in type 1 diabetes, suggesting disease link.
(1) Background: Neuropathies are common complications of type 1 diabetes (T1D) and previous research demonstrated concomitant demyelinization involving myelin basic protein (MBP). T1D patients have a significantly increased risk of multiple sclerosis (MS) and vice versa. The causes are unknown. (2) Methods: Proteonomic searches using BLAST were used to identify similarities between T-cell receptor (TCR) sequences from T1D and MS patients. LALIGN was used to explore whether T1D-related proteins mimic MBP. Enzyme-linked immunoadsorption assay (ELISA) was used to test for cross-reactivity between T1D-related antibodies or sera with MBP. Ultraviolet spectroscopy was used to test whether T1D-specific T-cell receptor (TCR) sequences recognized MBP. (3) Results: BLAST revealed that a subset of T1D and MS TCR are nearly identical. Sequence similarities were found by LALIGN between MBP and T1D-associated antigens. Antibodies against insulin, PTPRN(IA-2), and GAD1 recognized MBP. Most TCR sequences derived from T1D patients recognized MBP as an antigen. Most T1D-derived sera recognize MBP, but healthy sera do not. BLAST revealed that coxsackievirus proteins do not mimic MBP, but many Clostridia proteins do. (4) Conclusions: Cross-reactivity between TID-related antibodies and TCR with MBP may help to explain the pathogenesis of T1D neuropathies and the increased co-occurrence of these two diseases.
No takes yet. Share an insight, caveat, or question.
Robert Root‐Bernstein (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: